The M4 transmembrane segment contributes to agonist efficacy differences between α1 and α3 glycine receptors

References

• Ahmadi S, Lippross S, Neuhuber WL, Zeilhofer HU. PGE(2) selectively blocks inhibitory glycinergic neurotransmission onto rat superficial dorsal horn neurons. Nature Neurosci 2002; 5: 34–40
   PubMed Web of Science ®Google Scholar
• Antollini SS, Xu Y, Jiang H, Barrantes FJ. Fluorescence and molecular dynamics studies of the acetylcholine receptor gammaM4 transmembrane peptide in reconstituted systems. Mol Membr Biol 2005; 22: 471–483
   PubMed Web of Science ®Google Scholar
• Auerbach, A. 2003. Life at the top: The transition state of AChR gating. Sci STKE, , 2003:re11.
   Google Scholar
• Barrantes FJ. Modulation of nicotinic acetylcholine receptor function through the outer and middle rings of transmembrane domains. Curr Opin Drug Discov Devel 2003; 6: 620–632
   PubMedGoogle Scholar
• Blanton MP, Cohen JB. Identifying the lipid-protein interface of the Torpedo nicotinic acetylcholine receptor: Secondary structure implications. Biochemistry 1994; 33: 2859–2872
   PubMedGoogle Scholar
• Blanton MP, Cohen JB. Mapping the lipid-exposed regions in the Torpedo californica nicotinic acetylcholine receptor. Biochemistry 1992; 31: 3738–3750
   PubMedGoogle Scholar
• Bocquet N, Nury H, Baaden M, Le Poupon C, Changeux JP, Delarue M, Corringer PJ. X-ray structure of a pentameric ligand-gated ion channel in an apparently open conformation. Nature 2009; 457: 111–114
   PubMed Web of Science ®Google Scholar
• Bouzat C, Barrantes F, Sine S. Nicotinic receptor fourth transmembrane domain: Hydrogen bonding by conserved threonine contributes to channel gating kinetics. J Gen Physiol 2000; 115: 663–672
   Google Scholar
• Bouzat C, Gumilar F, del Carmen Esandi M, Sine SM. Subunit-selective contribution to channel gating of the M4 domain of the nicotinic receptor. Biophys J 2002; 82: 1920–1929
   Google Scholar
• Bouzat C, Roccamo AM, Garbus I, Barrantes FJ. Mutations at lipid-exposed residues of the acetylcholine receptor affect its gating kinetics. Mol Pharmacol 1998; 54: 146–153
   PubMed Web of Science ®Google Scholar
• Chen X, Cromer B, Webb TI, Yang Z, Hantke J, Harvey RJ, Parker MW, Lynch JW. Dihydropyridine inhibition of the glycine receptor: Subunit selectivity and a molecular determinant of inhibition. Neuropharmacol 2009; 56: 318–327
   PubMed Web of Science ®Google Scholar
• Colquhoun D. Binding, gating, affinity and efficacy: The interpretation of structure-activity relationships for agonists and of the effects of mutating receptors. Br J Pharmacol 1998; 125: 924–947
   PubMed Web of Science ®Google Scholar
• De Saint Jan D, David-Watine B, Korn H, Bregestovski P. Activation of human alpha1 and alpha2 homomeric glycine receptors by taurine and GABA. J Physiol (Lond) 2001; 535: 741–755
   Google Scholar
• Dellisanti CD, Yao Y, Stroud JC, Wang ZZ, Chen L. Crystal structure of the extracellular domain of nAChR alpha1 bound to alpha-bungarotoxin at 1.94 A resolution. Nature Neurosci 2007; 10: 953–962
   PubMed Web of Science ®Google Scholar
• Farroni JS, McCool BA. Extrinsic factors regulate partial agonist efficacy of strychnine-sensitive glycine receptors. BMC Pharmacol 2004; 4: 16
   PubMedGoogle Scholar
• Fernandez Nievas GA, Barrantes FJ, Antollini SS. Modulation of nicotinic acetylcholine receptor conformational state by free fatty acids and steroids. J Biol Chem 2008; 283: 21478–21486
   PubMed Web of Science ®Google Scholar
• Harvey RJ, Depner UB, Wassle H, Ahmadi S, Heindl C, Reinold H, Smart TG, Harvey K, Schutz B, Abo-Salem OM, Zimmer A, Poisbeau P, Welzl H, Wolfer DP, Betz H, Zeilhofer HU, Muller U. GlyR alpha3: An essential target for spinal PGE2-mediated inflammatory pain sensitization. Science 2004; 304: 884–887
   PubMed Web of Science ®Google Scholar
• Hilf RJ, Dutzler R. Structure of a potentially open state of a proton-activated pentameric ligand-gated ion channel. Nature 2009; 457: 115–118
   PubMed Web of Science ®Google Scholar
• Hilf RJ, Dutzler R. X-ray structure of a prokaryotic pentameric ligand-gated ion channel. Nature 2008; 452: 375–379
   PubMed Web of Science ®Google Scholar
• Jenkins A, Andreasen A, Trudell JR, Harrison NL. Tryptophan scanning mutagenesis in TM4 of the GABA(A) receptor alpha1 subunit: Implications for modulation by inhaled anesthetics and ion channel structure. Neuropharmacology 2002; 43: 669–678
   Google Scholar
• Kuhse J, Schmieden V, Betz H. Identification and functional expression of a novel ligand binding subunit of the inhibitory glycine receptor. J Biol Chem 1990; 265: 22317–22320
   PubMed Web of Science ®Google Scholar
• Lee YH, Li L, Lasalde J, Rojas L, McNamee M, Ortiz-Miranda SI, Pappone P. Mutations in the M4 domain of Torpedo californica acetylcholine receptor dramatically alter ion channel function. Biophys J 1994; 66: 646–653
   PubMedGoogle Scholar
• Lewis TM, Schofield PR, McClellan AM. Kinetic determinants of agonist action at the recombinant human glycine receptor. J Physiol (Lond) 2003; 549: 361–374
   Google Scholar
• Li L, Lee YH, Pappone P, Palma A, McNamee MG. Site-specific mutations of nicotinic acetylcholine receptor at the lipid-protein interface dramatically alter ion channel gating. Biophys J 1992; 62: 61–63
   PubMedGoogle Scholar
• Lobo IA, Trudell JR, Harris RA. Accessibility to residues in transmembrane segment four of the glycine receptor. Neuropharmacol 2006; 50: 174–181
   PubMed Web of Science ®Google Scholar
• Lynch JW. Molecular structure and function of the glycine receptor chloride channel. Physiol Revs 2004; 84: 1051–1095
   PubMed Web of Science ®Google Scholar
• Lynch JW. Native glycine receptor subtypes and their physiological roles. Neuropharmacology 2009; 56: 303–309
   PubMed Web of Science ®Google Scholar
• Lynch JW, Callister RJ. Glycine receptors: A new therapeutic target in pain pathways. Curr Opin Investig Drugs 2006; 7: 48–53
   PubMedGoogle Scholar
• Lynch JW, Rajendra S, Pierce KD, Handford CA, Barry PH, Schofield PR. Identification of intracellular and extracellular domains mediating signal transduction in the inhibitory glycine receptor chloride channel. EMBO J 1997; 16: 110–120
   PubMed Web of Science ®Google Scholar
• Meier JC, Henneberger C, Melnick I, Racca C, Harvey RJ, Heinemann U, Schmieden V, Grantyn R. RNA editing produces glycine receptor alpha3(P185L), resulting in high agonist potency. Nature Neurosci 2005; 8: 736–744
   PubMed Web of Science ®Google Scholar
• Miller PS, Beato M, Harvey RJ, Smart TG. Molecular determinants of glycine receptor alphabeta subunit sensitivities to Zn2 + -mediated inhibition. J Physiol (Lond) 2005; 566: 657–670
   Google Scholar
• Mitra A, Bailey TD, Auerbach AL. Structural dynamics of the M4 transmembrane segment during acetylcholine receptor gating. Structure 2004; 12: 1909–1918
   Google Scholar
• Nikolic Z, Laube B, Weber RG, Lichter P, Kioschis P, Poustka A, Mulhardt C, Becker CM. The human glycine receptor subunit alpha3. Glra3 gene structure, chromosomal localization, and functional characterization of alternative transcripts. J Biol Chem 1998; 273: 19708–19714
   PubMed Web of Science ®Google Scholar
• Rajendra S, Lynch JW, Pierce KD, French CR, Barry PH, Schofield PR. Mutation of an arginine residue in the human glycine receptor transforms beta-alanine and taurine from agonists into competitive antagonists. Neuron 1995; 14: 169–175
   PubMed Web of Science ®Google Scholar
• Schmieden V, Kuhse J, Betz H. Agonist pharmacology of neonatal and adult glycine receptor alpha subunits: Identification of amino acid residues involved in taurine activation. EMBO J 1992; 11: 2025–2032
   PubMed Web of Science ®Google Scholar
• Taleb O, Betz H. Expression of the human glycine receptor alpha 1 subunit in Xenopus oocytes: Apparent affinities of agonists increase at high receptor density. EMBO J 1994; 13: 1318–1324
   Google Scholar
• Tamamizu S, Lee Y, Hung B, McNamee MG, Lasalde-Dominicci JA. Alteration in ion channel function of mouse nicotinic acetylcholine receptor by mutations in the M4 transmembrane domain. J Membr Biol 1999; 170: 157–164
   Google Scholar
• Unwin N. Refined structure of the nicotinic acetylcholine receptor at 4A resolution. J Mol Biol 2005; 346: 967–989
   PubMed Web of Science ®Google Scholar
• Villmann C, Oertel J, Ma-Hogemeier ZL, Hollmann M, Sprengel R, Becker K, Breitinger HG, Becker CM. Functional complementation of Glra1(spd-ot), a glycine receptor subunit mutant, by independently expressed C-terminal domains. J Neurosci 2009; 29: 2440–2452
   PubMed Web of Science ®Google Scholar
• Xiu X, Hanek AP, Wang J, Lester HA, Dougherty DA. A unified view of the role of electrostatic interactions in modulating the gating of Cys loop receptors. J Biol Chem 2005; 280: 41655–41666
   PubMed Web of Science ®Google Scholar
• Yang Z, Aubrey KR, Alroy I, Harvey RJ, Vandenberg RJ, Lynch JW. Subunit-specific modulation of glycine receptors by cannabinoids and N-arachidonyl-glycine. Biochem Pharmacol 2008; 76: 1014–1023
   PubMed Web of Science ®Google Scholar
• Yang Z, Cromer BA, Harvey RJ, Parker MW, Lynch JW. A proposed structural basis for picrotoxinin and picrotin binding in the glycine receptor pore. J Neurochem 2007; 103: 580–589
   PubMed Web of Science ®Google Scholar
• Zeilhofer HU. Synaptic modulation in pain pathways. Rev Physiol Biochem Pharmacol 2005; 154: 73–100
   PubMed Web of Science ®Google Scholar
• Zhang XB, Sun GC, Liu LY, Yu F, Xu TL. Alpha2 subunit specificity of cyclothiazide inhibition on glycine receptors. Mol Pharmacol 2008; 73: 1195–1202
   PubMed Web of Science ®Google Scholar